Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Description

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Conditions

Antiphospholipid Syndrome

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Condition
Antiphospholipid Syndrome
Intervention / Treatment

-

Contacts and Locations

Sacramento

UC Davis Medical Center, Sacramento, California, United States, 95817

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years of age or younger at the onset of disease
  • * Presence of Vascular Thrombosis
  • * UC Davis patient
  • * Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma
  • * Infants born to mothers with APS
  • * Infants with congenital thrombophilia

Ages Eligible for Study

1 Minute to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, Davis,

Lavjay Butani, M.D., PRINCIPAL_INVESTIGATOR, University of California, Davis

Study Record Dates

2040-01